Tokyo Tape
Sign in
← Takeda Pharmaceutical

Half-year report · HY

4502.TEDINET S100WX9G
Period2025-04-01 → 2025-09-30
Filed2025-10-30
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥2.22T2025-04-01 → 2025-09-30Cons.Revenue IFRS
Revenue¥4.58T2024-04-01 → 2025-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥2.38T2024-04-01 → 2024-09-30Cons.Revenue IFRS
Operating income¥253.6bn2025-04-01 → 2025-09-30Cons.Operating profit loss IFRS
Operating income¥350.6bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Profit before tax¥178.8bn2025-04-01 → 2025-09-30Cons.Profit loss before tax IFRS
Profit before tax¥175.1bn2024-04-01 → 2025-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥256.0bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥112.4bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥107.9bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥187.3bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥112.5bn2025-04-01 → 2025-09-30Cons.Profit loss IFRS
Net income¥108.1bn2024-04-01 → 2025-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥187.4bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Total assets¥14.47Tat 2025-09-30Cons.Assets IFRS
Total assets¥14.25Tat 2025-03-31Cons.Assets IFRS
Total assets¥14.57Tat 2024-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥7.34Tat 2025-09-30Cons.Liabilities IFRS
Total liabilities¥7.31Tat 2025-03-31Cons.Liabilities IFRS
Net assets / equity¥7.13Tat 2025-09-30Cons.Equity IFRS
Net assets / equity¥6.94Tat 2025-03-31Cons.Equity IFRS
Net assets / equity¥6.92Tat 2024-09-30Cons.Equity IFRS
Net assets / equity¥7.27Tat 2024-03-31vCons.Equity IFRS
Equity (owners)¥7.13Tat 2025-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥6.94Tat 2025-03-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥681.5bnat 2025-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥385.1bnat 2025-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥859.0bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥457.8bnat 2024-03-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥593.7bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥1.06T2024-04-01 → 2025-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥451.3bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥81.3bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥367.1bn2024-04-01 → 2025-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥231.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥226.9bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥751.4bn2024-04-01 → 2025-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥206.3bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥71.572025-04-01 → 2025-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥68.362024-04-01 → 2025-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥118.852024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥70.452025-04-01 → 2025-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥67.232024-04-01 → 2025-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥117.112024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio49.3%at 2025-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio48.7%at 2025-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio47.5%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 660
ItemContextValueUnit
Equity IFRSPrior1YearInstant_CapitalSurplusIFRSMember1775713000000JPY
Equity IFRSPrior1YearInstant_TreasurySharesIFRSMember-74815000000JPY
Equity IFRSPrior1YearInstant_RetainedEarningsIFRSMember1187586000000JPY
Equity IFRSPrior1YearInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember2419978000000JPY
Equity IFRSPrior1YearInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember4757000000JPY
Profit loss IFRSInterimDuration_RetainedEarningsIFRSMember112441000000JPY
Other comprehensive income IFRSInterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember204710000000JPY
Other comprehensive income IFRSInterimDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember27311000000JPY
Comprehensive income IFRSInterimDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSInterimDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSInterimDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSInterimDuration_RetainedEarningsIFRSMember112441000000JPY
Comprehensive income IFRSInterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember204710000000JPY
Comprehensive income IFRSInterimDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember27311000000JPY
Issuance of new shares ss IFRSInterimDuration_ShareCapitalIFRSMember74000000JPY
Issuance of new shares ss IFRSInterimDuration_CapitalSurplusIFRSMember74000000JPY
Purchase of treasury shares ss IFRSInterimDuration_CapitalSurplusIFRSMember-20000000JPY
Purchase of treasury shares ss IFRSInterimDuration_TreasurySharesIFRSMember-51610000000JPY
Dividends ss IFRSInterimDuration_RetainedEarningsIFRSMember-154411000000JPY
Transfer from other components of equity to retained earnings ss IFRSInterimDuration_RetainedEarningsIFRSMember3042000000JPY
Transfer from other components of equity to retained earnings ss IFRSInterimDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-2285000000JPY
Share based compensation ss IFRSInterimDuration_CapitalSurplusIFRSMember36219000000JPY
Exercise of share based awards ss IFRSInterimDuration_CapitalSurplusIFRSMember-77301000000JPY
Exercise of share based awards ss IFRSInterimDuration_TreasurySharesIFRSMember77301000000JPY
Transfers to other comprehensive income related to assets held for sale ss IFRSInterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember3595000000JPY
Total transactions with owners IFRSInterimDuration_ShareCapitalIFRSMember74000000JPY
Total transactions with owners IFRSInterimDuration_CapitalSurplusIFRSMember-41028000000JPY
Total transactions with owners IFRSInterimDuration_TreasurySharesIFRSMember25691000000JPY
Total transactions with owners IFRSInterimDuration_RetainedEarningsIFRSMember-151369000000JPY
Total transactions with owners IFRSInterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember3595000000JPY
Total transactions with owners IFRSInterimDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-2285000000JPY
Equity IFRSInterimInstant_ShareCapitalIFRSMember1694759000000JPY
Equity IFRSInterimInstant_CapitalSurplusIFRSMember1734685000000JPY
Equity IFRSInterimInstant_TreasurySharesIFRSMember-49124000000JPY
Equity IFRSInterimInstant_RetainedEarningsIFRSMember1148658000000JPY
Equity IFRSInterimInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember2628283000000JPY
Equity IFRSInterimInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember29782000000JPY
Equity IFRSPrior1YearInstant_EffectivePortionOfCashFlowHedgesIFRSMember-64852000000JPY
Equity IFRSPrior1YearInstant_jpcrp040300-ssr_E00919-000HedgingCostIFRSMember-7967000000JPY
Equity IFRSPrior1YearInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Equity IFRSPrior1YearInstant_OtherComponentsOfEquityIFRSMember2351915000000JPY
Equity IFRSPrior1YearInstant_jpcrp040300-ssr_E00919-000OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember－JPY
Equity IFRSPrior1YearInstant_EquityAttributableToOwnersOfParentIFRSMember6935084000000JPY
Equity IFRSPrior1YearInstant_NonControllingInterestsIFRSMember895000000JPY
Equity IFRSPrior1YearInstant6935979000000JPY
Profit loss IFRSInterimDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSInterimDuration_EquityAttributableToOwnersOfParentIFRSMember112441000000JPY
Profit loss IFRSInterimDuration_NonControllingInterestsIFRSMember108000000JPY
Profit loss IFRSInterimDuration112550000000JPY
Other comprehensive income IFRSInterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember16611000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass